World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
48
Citations
7897
World Ranking
4444
National Ranking
2013

Lucy Golden-Mason publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Lucy Golden-Mason sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 118 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Lucy Golden-Mason D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Lucy Golden-Mason sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 48 D-Index — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Lucy Golden-Mason is affiliated with the University of Southern California in the United States. Their research spans the fields of Medicine and Immunology and Microbiology, with a focus on several interrelated subfields including Immunology, Epidemiology, Health, Toxicology and Mutagenesis, Pediatrics, Perinatology and Child Health, and Environmental Chemistry.

Their work covers a range of topics that include:

  • Immune Cell Function and Interaction
  • Liver Disease Diagnosis and Treatment
  • T-cell and B-cell Immunology
  • Birth, Development, and Health
  • Immune cells in cancer
  • Per- and polyfluoroalkyl substances research
  • Renal Transplantation Outcomes and Treatments

Golden-Mason has co-authored research with several frequent collaborators, including:

  • Ana C. Maretti-Mira
  • Hugo R. Rosen
  • Matthew P. Salomon
  • Lida Chatzi
  • Damaskini Valvi

Their recent publications demonstrate a focus on liver disease, immune system interactions, and environmental health impacts. Selected recent papers include:

  • "In Utero Exposure to Mercury Is Associated With Increased Susceptibility to Liver Injury and Inflammation in Childhood" (2021), published in Hepatology
  • "Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease" (2021), published in iScience
  • "Cholesterol-Induced M4-Like Macrophages Recruit Neutrophils and Induce NETosis" (2021), published in Frontiers in Immunology
  • "Autophagy impairment in liver CD11c+ cells promotes non-alcoholic fatty liver disease through production of IL-23" (2022), published in Nature Communications
  • "Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development" (2020), published in PLoS ONE

Golden-Mason has frequently published in the following venues:

  • Frontiers in Immunology
  • Zenodo (CERN European Organization for Nuclear Research)
  • Environmental Research
  • Hepatology
  • iScience

Best Publications

  • Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4+ and CD8+ T Cells

    Lucy Golden-Mason;Brent E. Palmer;Nasim Kassam;Lisa Townshend-Bulson

  • Transmigrating Neutrophils Shape the Mucosal Microenvironment through Localized Oxygen Depletion to Influence Resolution of Inflammation

    Eric L. Campbell;Walter J. Bruyninckx;Caleb J. Kelly;Louise E. Glover

  • Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune Dysfunction

    Lucy Golden-Mason;Brent Palmer;Jared Klarquist;John A. Mengshol

  • Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity

    Rachel H. McMahan;Lucy Golden-Mason;Michael I. Nishimura;Brian J. McMahon

  • Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease.

    Rachel H. McMahan;Xiaoxin X. Wang;Lin Ling Cheng;Tibor Krisko

  • A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C Infection

    John A. Mengshol;Lucy Golden-Mason;Tomohiro Arikawa;Maxwell Smith

  • Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes

    Sarah M. Williams;Lucy Golden-Mason;Bradley S. Ferguson;Katherine B. Schuetze

  • Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure

    Lucy Golden-Mason;Laura Madrigal-Estebas;Emma McGrath;Melissa J Conroy

  • Distinct subpopulations of gamma delta T cells are present in normal and tumor-bearing human liver.

    Tony Kenna;Lucy Golden-Mason;Suzanne Norris;John E. Hegarty

  • Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high‐risk individuals and inhibits replication in vitro

    Lucy Golden-Mason;Andrea L. Cox;Jessica A. Randall;Linling Cheng

  • Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences.

    Lucy Golden-Mason;Jared Klarquist;Abdus S. Wahed;Hugo R. Rosen

  • Galectin-9 Functionally Impairs Natural Killer Cells in Humans and Mice

    Lucy Golden-Mason;Rachel H. McMahan;Rachel H. McMahan;Michael Strong;Richard Reisdorph

  • Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence

    Lucy Golden-Mason;James R. Burton;Nicole Castelblanco;Jared Klarquist

  • Natural killer cells: primary target for hepatitis C virus immune evasion strategies?

    Lucy Golden-Mason;Hugo R. Rosen

  • Decrease in hepatic CD56+ T cells and Vα24+ natural killer T cells in chronic hepatitis C viral infection

    Tina Deignan;Michael P Curry;Derek G Doherty;Lucy Golden-Mason

  • Mechanisms of Disease: HCV-induced liver injury.

    John A Mengshol;Lucy Golden-Mason;Hugo R Rosen

  • Acute‐phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF‐κB–dependent signal transduction pathway

    Ronan H. Mullan;Barry Bresnihan;Lucy Golden-Mason;Trevor Markham

  • Regulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection.

    Afework Kassu;Roland A. Marcus;Michelle B. D’Souza;Elizabeth A. Kelly-McKnight

  • Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.

    Celeste C. Goh;Krystal M. Roggerson;Hai-Chon Lee;Lucy Golden-Mason

  • Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals.

    M. A. Burchill;L. Golden-Mason;M. Wind-Rotolo;H. R. Rosen

Frequent Co-Authors

Hugo R. Rosen
Hugo R. Rosen University of Southern California
Cliona O'Farrelly
Cliona O'Farrelly Trinity College Dublin
Derek G. Doherty
Derek G. Doherty Trinity College Dublin
Brent E. Palmer
Brent E. Palmer University of Colorado Denver
Sean P. Colgan
Sean P. Colgan University of Colorado Anschutz Medical Campus
Michael Gale
Michael Gale University of Washington
Young S. Hahn
Young S. Hahn University of Virginia
Ursula Fearon
Ursula Fearon Trinity College Dublin
Brian J. McMahon
Brian J. McMahon Centers for Disease Control and Prevention
Barry Bresnihan
Barry Bresnihan University College Dublin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology can open doors to diverse healthcare roles, many of which benefit from advanced nursing degrees. For those interested in mental health, affordable affordable pmhnp programs offer accessible paths to become Psychiatric Mental Health Nurse Practitioners, integrating immunological insights with patient care.

Nurses seeking growth might consider the Doctor of Nursing Practice (DNP), which can significantly impact earning potential. Reviewing dnp salary data can help candidates understand financial benefits across regions.

Many professionals start as Family Nurse Practitioners and transition to specialized areas. Guidance on how to navigate this change is outlined in resources on fnp to acute care np, aiding those aiming to move into acute care settings where immunology knowledge is critical.

For accelerated options, students can explore top-tier programs through listings like the accelerated fnp programs, which fast-track Family Nurse Practitioner education, enabling quicker entry into healthcare careers connected to immunology.

Best Scientists Citing Lucy Golden-Mason

Trending Scientists

Recently Published Articles